Table of Content

Scope and Methodology
1.1. Research Methodology
1.2. Scope of the Market

2. Key Trends and Developments

3. Executive Summary
3.1. Market Snippet by Technology
3.2. Market Snippet by Method
3.3. Market Snippet by Application
3.4. Market Snippet by Region

4. Market Dynamics
4.1. Market impacting factors
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Impact analysis

5. Industry Analysis
5.1. Porter’s five forces analysis
5.2. Value chain analysis
5.3. Patent Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives

7. By Technology
7.1. Introduction
7.1.1. Market size analysis, and y-o-y growth analysis (%), By Technology Segment
7.1.2. Market attractiveness index, By Technology Segment
7.2. Separation Tools *
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
7.3. High-Performance Liquid Chromatography
7.4. Bioinformatic Tools, Databases & Services
7.5. Others

8. By Method
8.1. Introduction
8.1.1. Market size analysis, and y-o-y growth analysis (%), By Method Segment
8.1.2. Market attractiveness index, By Method Segment
8.2. Cancer *
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
8.3. Cardiovascular Diseases
8.4. Neurological Diseases
8.5. Others

9. By Application
9.1. Introduction
9.1.1. Market size analysis, and y-o-y growth analysis (%), By Application Segment
9.1.2. Market attractiveness index, By Application Segment
9.2. Biomarker and Drug Discovery *
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
9.3. Toxicology
9.4. Nutrigenomics
9.5. Personalized Medicines
9.6. Others

10. By Region
10.1. Introduction
10.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key region-specific dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. South America
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
10.3.6.1. Brazil
10.3.6.2. Argentina
10.3.6.3. Rest of South America
10.4. Europe
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
10.4.6.1. Germany
10.4.6.2. U.K.
10.4.6.3. France
10.4.6.4. Spain
10.4.6.5. Italy
10.4.6.6. Rest of Europe
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape
11.1. Competitive scenario
11.2. Competitor strategy analysis
11.3. Market positioning/share analysis
11.4. Mergers and acquisitions analysis

12. Company Profiles
12.1. AB Sciex Pte. Ltd. *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Agilent Technologies
12.3. Beckman Coulter, Inc.
12.4. Bio-Rad Laboratories, Inc.
12.5. Bruker Corporation
12.6. GE Healthcare
12.7. Human Metabolome Technologies, Inc.
12.8. LECO Corporation
12.9. Merck KGaA
12.10. Metabolon, Inc.
12.11. Hua Medicine
12.12. 3SBio Group
12.13. Shanghai Fosun Pharmaceutical?Group?Co., Ltd.
12.14. Innovent Biologics
12.15. Huadong Medicine Co., Ltd.
*List not Exhaustive*

13. DataM
13.1. Appendix
13.2. About us and services
13.3. Contact us